Early Diagnosis of Therapy-associated Cardiotoxicity Basing on PET/CT in Lymphoma

Positron Nuclide Labeled NOTA-FAPI PET Study in Lymphoma

NCT04367948 ·Status: UNKNOWN ·Phase: NA

Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Diffuse Large B-cell Lymphoma

NCT02931201 ·Status: UNKNOWN ·Phase: NA

Prospective Comparison Between FDG-PET/MR and FDG-PET/CT in Classical Hodgkin Lymphoma and DLBC Non-Hodgkin Lymphoma

NCT03042247 ·Status: UNKNOWN

Total-body PET / CT in the Evaluation of Treatment and Prognosis of Lymphoma

NCT04931875 ·Status: UNKNOWN

PET-CT in Lymphoma Among the Eldery

NCT07259941 ·Status: NOT_YET_RECRUITING

Positron Emission Tomography (PET)-Scan in the Evaluation of High Tumor Burden Follicular Lymphoma

NCT00915096 ·Status: COMPLETED

Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Peripheral T-cell Lymphoma

NCT03051568 ·Status: UNKNOWN ·Phase: NA

The Performance of Multi-tracer Multimodality PET in Lymphoma

NCT05004961 ·Status: UNKNOWN

18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Peripheral T-cell Lymphoma

NCT03051581 ·Status: UNKNOWN ·Phase: NA

PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma

NCT05662540 ·Status: RECRUITING ·Phase: NA

MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma

NCT02733887 ·Status: UNKNOWN ·Phase: NA

A Study Evaluating the Value of 68Ga-Pentixafor PET Imaging in the Staging of Hematological Tumor, and Comparing It with 18F-FDG PET/CT Imaging

NCT06834412 ·Status: RECRUITING ·Phase: NA

Clinical Application of 99mTc-FDPH46 SPECT/CT Imaging in Malignant Solid Tumor: a Prospective Exploratory Study

NCT06753513 ·Status: NOT_YET_RECRUITING

Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma

NCT00110006 ·Status: WITHDRAWN ·Phase: NA

68Ga-grazytracer PET/CT of Tumor Responses to Immunotherapy

NCT05000372 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Early Response Assessment in Diffuse Large B-Cell Lymphoma (DLCL) Patients by 18-fluoro-2-deoxyglycose Positron Emission Tomography (FDG-PET)

NCT00754117 ·Status: COMPLETED

Use of FDG PET as Predictor of Residual Disease and Subsequent Relapse in Patients With NHL and HD Undergoing HDC and ASCT

NCT00534989 ·Status: COMPLETED ·Phase: NA

Non-invasive Evaluation of Lymphoma Patients Based on Artificial Intelligence and PET/MRI

NCT04154228 ·Status: UNKNOWN ·Phase: NA

Early Evaluation of the Response of Large B Cell Non Hodgkin's Lymphoma to Chemotherapy by PET/CT

NCT00256490 ·Status: COMPLETED ·Phase: NA

PET/MR in Assessing Response to Neoadjuvant Radiation Therapy in the Tx of High Grade Sarcomas

NCT03076333 ·Status: COMPLETED ·Phase: NA

FDG PET/CT and Directed Metabolic Core Needle Biopsy in the Management of Lymphoma

NCT05186610 ·Status: COMPLETED

Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors

NCT06182644 ·Status: RECRUITING ·Phase: NA

Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers

NCT01421953 ·Status: COMPLETED ·Phase: NA

18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Diffuse Large B-cell Lymphoma

NCT02928861 ·Status: UNKNOWN ·Phase: NA

FDG PET-CT for Lymphoma Radiotherapy Planning Version 1.3

NCT01999998 ·Status: UNKNOWN ·Phase: NA